Ancient indian insights and modern discoveries in nutrition, exercise and weight control

Journal of Association of Physicians of India

Volumn 60, Issue 1, 2012, Pages 30-41

  Lele, R D ^a  

^a LILAVATI HOSPITAL AND RESEARCH CENTRE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AYURVEDA; BODY MASS; DIET; ETHNOLOGY; EXERCISE; FEEDING BEHAVIOR; GENETICS; HEALTH BEHAVIOR; HEALTH PROMOTION; HUMAN; METHODOLOGY; OBESITY; THERMOGENESIS;

BODY MASS INDEX; DIET; EXERCISE; FOOD HABITS; HEALTH BEHAVIOR; HEALTH PROMOTION; HUMANS; MEDICINE, AYURVEDIC; OBESITY; OVERWEIGHT; THERMOGENESIS;

EID: 84855520868     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Lele RD. Quotes from Charak Samhita. Ayurveda and Modern Medicine, 1986, 2nd Edition 2001, Bharatiya Vidya Bhavan, Mumbai.
2. Devasagayam TPA, Tilak JC, Boloon KK, Sam KS, Gadkari SS, Lele RD. Free Radicals and anti-oxidants in human health. Current status and future prospects JAPI 2004;52:794-806.
3. Narsimhan LM et al. 2005. Osmotin is a plant homolog of mammalian adiponectin and acts through adiponectin receptors.
4. Wolf G. Adiponectin, a regulator of energy homeostasis. Nutr Rev 2003;61:290-92.
5. Ariel A, Serhan CN. Resolvins and protectins in the termination program of acute inflammation. Trends Immunol 2007;28:176-183.
6. Bannenberg G, Serhan CN. Specialized pro-solvins; Biochem. Biophys Acts 2010;1801:1260-73.
7. U avy R, Dangour AD. Nutrition in brain development and aging: role of essential fatty acids. Nutr Rev 2006;64:524-33.
8. Empana JP et al. Contribution of depressive mood and circulating inflammatory markers to coronary Heart Disease in Healthy European men. The prospective Epidemiological study of myocardial infarction (PRIME). Circulation 2005;111:2299-2305.
9. Colin A et al. Lipids, depression and suicide. Encephale 2003;29:49-58.
10. Hamazaki KJ et al. N3 PUFA modulate sympathetic activity Dietary supplement with DHA for 3 months prevented young students for developing aggressive behaviour at times of stress. Clin Invest 1996;97:1129-33.
11. Engler MM et al. Early study - role of DHA in restoring endothelial function in children with hyperlipidemia. Int J Clin Pharmacol Ther 2004;42:672-9.
12. Tagawa H. et al. J. Long-term treatment with EPA/DHA augment NO-medicated as well as non-NO medicated endothelium dependent vasodilation. Cardiovasc Pharmacol 1999;33:633-40.
13. Siscovick DS et al. Dietary intake and cell membrane levels of long chain n-3 polyunsaturated fatty acids and risk of primary cardiac arrest. JAMA 1996;275:836-7.
14. Albert et al. Blood levels of W3 FAs and risk of sudden death. NEJM 2002;346:1113-8.
15. Thies et al. Association of W3 FAs with stability of atherosclerotic plaque. A randomized controlled trial. Lancet 2003;361:477-85.
16. Block RC et al. EPA and DHA in blood cell membrane from acute coronary syndrome patients and controls. Atherosclerosis 2008;197:821-28.
17. Kummerow FA et al. Trans- fatty acids in hydrogenated fat inhibits the synthesis of the polyunsaturated fatty acids in the phospholipids of arterial cells. Life Sc 2004;74:2707-23.
18. Calder PC. Dietary modification of inflammation with lipids. Proc Nutr Sc 2002;61:345-358.
19. Wilkinson RJ et al. Influence of Vit. D deficiency and Vit. D receptor polymorphism on Tuberculosis among Gujarathi Asian Indian in west London: a case control study. Lancet 2000;355:618-21.
20. R oche HM. Two way interaction between nutrition & human genome. Biochem Soc Trans 2004;32:993-1002.
21. Surh YJ. Cancer chemoprevention with dietary phyto chemicals. Nature Rev Cancer 2003:3:768-80.
22. Bolinder J. et al. β-Adrenergic regulation of lipolysis and blood flow in human skeletal muscle in vivo. Am J Physiol Endocrinol Metab 1998;275:E909-E916.
23. Palou A, Serra F, Bonel ML. Picoc obesity; Molecular bases of a multifactorial problem. Eur J Nutr 2000;39:127-144.
24. Bonet ML et al. Cellular and Molecular Life Sciences 2003;60;1311-21.
25. Wood RJ. Nutrition Rev 2008;66:40-46.
26. Gura T. Uncoupling proteins provide new clues to obesity causes. Science 1998;280:1369-70.
27. Cinti S. The role of BAT in human obesity. Nutr Metlab Cardiovas Dis 2006;16:569-74.
28. Fleury C et al. Uncoupling protein 2 a new gene link between obesity and hyperinsulinism. Nature Genetics 1997;15:269-272.
29. Kubota T et al. Screening of UCP2 gene in patients with NIDDM or obesity. Clin Endocr Metab 1998;83:2800-2804.
30. Boss et al. UCP3 a new member of the mitochondrial carrier family with tissue specific expression. FEBS Letter 1997;408:39-42.
31. Cassell PG et al. Evidence that a single nucleotide polymorphism in UCP3 gene influences fat distribution in women of European and Asian origin. Diabetologia 2000;43:1558-64.
32. Klaus S et al. Expression of UCP-3 in skeletal muscle decreases muscle energy efficiency and affects thermoregulation and substrate oxidation. Physical Genomics 2005;21:193-200.
33. Gong DW et al. UCP-3 is a mediator of thermogenesis regulated by thyroid hormone, β3 adrenergic agonists and leptin. J Biol Chem 1997;272:24129-32.
34. Chow LS et al. Mechanism of insulin anabolic effect in muscle measurement of muscle protein synthesis and breakdown using aminoacyl tRNA and other surrogate markers. Amer J Physiol Endocr Metlab 2006;291:E729-E736.
35. Lele RD. Fat and muscle component of Body Mass Index (BMI): relation with hyperinsulinemia. JAPI 2007;55:203-209.
36. Goldberg M. and Gordon ES. Strong mesomorphic component in overweight females with T2DM and CAD. JAMA 1964;189:616.
37. Lele RD, Naik RS. A study of the relationship between obesity and diabetes: Proceedings of the First World Congress of Diabetes: in the Tropics. Bombay 1966;421-428.
38. Peterson KF et al. NEJM 2004;350:664-71.
39. Baur AL et al. Relationship between maternal risk of insulin resistance and the child's muscle membrane fatty acid composition. Diabetes 1999;48:112-116.
40. Towler MC, Hardic DG, AMP-activated protein kinase in metabolic control and insulin signalling. Cir Res 2007;100:328-341.
41. Kim MS et al. Anti-obesity effect of alpha lipoic acid mediated by suppression of hypothalamic AMPK. Nature Med 2004;10:727-722.
42. Carling D. AMPK- balancing of the scales. Biochimie 2005;87:87-91.
43. Lele RD. Proinsulin, C peptide, glycagon, adiponectin TNFα and AMPK-six neglected players in T2DM. JAPI 2010;58:30-36.
44. Chau MDL et al. Fibroblast Growth Factor 21 regulates energy metabolism by activating AMPK-SIRTI- PGCia pathways. PNAS 2010.
45. Kranion Y et al. Effects of exercise n GLUT-4 and glycogenin gene expression in human skeletal muscle. J Appl Physiol 2000;88:794-96.
46. Ostergard T et al. Impact of exercise training on insulin sensitivity, physical fitness and muscle oxidative capacity in first degree relatives of T2DM patient. Amer J Endo Metab 2006;290:99-105.
47. Valenti M et al. Physical exercise and quality of life in breast cancer survivors. Int J Med Sc 2008;5:24-28.
48. Nickel T et al. Immunomodulatory effects of aerobic training in obesity. Mediators of inflammation 2011.
49. Ornish DM et al. Effects of stress management training and dietary changes in treating ischaemic heart disease. JAMA 1983;249:54-59.
50. Yogendra J, Hansa J, Yogendra S, Ambardekar S, Lele RD et al. Beneficial effects of Yoga Life Style on reversibility of ischaemic heart disease. Caring Heart Project of International Board of Yoga. JAPI 2007;52:283-88.